Stocks and Investing Stocks and Investing
Mon, November 15, 2021
Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021

Dane Leone Maintained (BPMC) at Strong Buy with Increased Target to $133 on, Nov 10th, 2021


Published on 2024-10-27 18:36:18 - WOPRAI, Dane Leone
  Print publication without navigation


Dane Leone of Raymond James, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $122 to $133 on, Nov 10th, 2021.

Dane has made no other calls on BPMC in the last 4 months.



There are 2 other peers that have a rating on BPMC. Out of the 2 peers that are also analyzing BPMC, 1 agrees with Dane's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Friday, October 29th, 2021


This is the rating of the analyst that currently disagrees with Dane


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 28th, 2021